Arguably, the World's First Real-time Pathogen Detection Device
In a notable advancement for the fast-moving consumer goods (FMCG) industry, Spore.Bio, a deeptech startup, has recently raised €8 million in …
Premium Articles
7 Notable Companies Empowering Women’s Health with AI
With over half of the world's population being female, it's only natural that the world of femtech is experiencing a …
9 Notable AI Companies in Clinical Research to Watch in 2023
The clinical trial is a critical stage of drug development workflow, with an estimated average success rate of about 11% …
Biopharma Industry Review: A Year of Challenges and Changes in 2023
The biopharma industry experienced a challenging year in 2023, marked by a significant decrease in funding and a high number …
The Rising Popularity of Antibody-Drug Conjugates, with Challenges
In the current climate of global economic uncertainty, one area of pharmaceutical development is bucking the trend with a significant …
ArtiDock from Receptor.AI: Next-generation AI Docking That Beats DiffDock and AlphaFold-latest
Receptor.AI has announced ArtiDock, the best-in-class model for “AI docking," which predicts the binding poses of small molecule ligands in protein …
Tech-First Companies Take the Lead in AI Drug Discovery
In recent news, Recursion (NASDAQ: RXRX), a prominent clinical stage TechBio firm, has announced the signing of agreements to acquire …
Insilico Medicine’s Generative AI Patent Provides Advantage in AI Drug Discovery Race
Companies are increasingly turning to generative artificial intelligence (AI) to develop new therapeutics, giving biotech companies with patents on these …
Maturing Pharma 4.0: How Digital Transformation Continues To Reshape Pharmaceuticals
The digital transformation of biopharmaceutical manufacturing has continued at a rapid pace as companies mine the rich sources of data …
From Data to Treatment: Medidata's Fareed Melhem Discusses AI's Impact on Clinical Trials
As the potential of artificial intelligence (AI) continues to unfold, how is it revolutionizing the intricate landscape of clinical trials? …
From Gene Editing to Pathway Design: How AI is Transforming Synthetic Biology
It is hard to overestimate the potential of biotechnology to address some of the most pressing challenges of the 21st …
Blending Biology and AI: Dr. Markus Gershater on the Future of Life Sciences
In the dynamic field of life sciences, both biological research and AI are coming together to alter our perspective on …